Neuropsychiatric Symptoms of Moyamoya Disease: Considerations for the Clinician

References

• Suzuki J, Takaku A. Cerebrovascular ”moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–299. doi:10.1001/archneur.1969.00480090076012
   PubMedGoogle Scholar
• Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65(6):956–958. doi:10.1212/01.wnl.0000176066.33797.82
   PubMed Web of Science ®Google Scholar
• Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(Suppl 2):S1–S5. doi:10.1016/s0303-8467(97)00031-0
   PubMedGoogle Scholar
• Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2–11. doi:10.5853/jos.2015.01627
   PubMed Web of Science ®Google Scholar
• Kuroda S, Fujimura M, Takahashi J, et al. Diagnostic criteria for moyamoya disease - 2021 revised version. Neurol Med Chir. 2022;62(7):307–312. doi:10.2176/jns-nmc.2022-0072
   PubMedGoogle Scholar
• Scala M, Vennarini S, Garrè ML, et al. Radiation-induced moyamoya syndrome after proton therapy in child with clival chordoma: natural history and surgical treatment. World Neurosurg. 2019;123:306–309. doi:10.1016/j.wneu.2018.12.048
   PubMed Web of Science ®Google Scholar
• Scala M, Fiaschi P, Cama A, et al. Radiation-induced moyamoya syndrome in children with brain tumors: case series and literature review. World Neurosurg. 2020;135:118–129. doi:10.1016/j.wneu.2019.11.155
   PubMed Web of Science ®Google Scholar
• Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–1066. doi:10.1016/s1474-4422(08)70240-0
   PubMed Web of Science ®Google Scholar
• Sato Y, Kazumata K, Nakatani E, Houkin K, Kanatani Y. Characteristics of moyamoya disease based on national registry data in Japan. Stroke. 2019;50(8):1973–1980. doi:10.1161/strokeaha.119.024689
   PubMed Web of Science ®Google Scholar
• Hirano Y, Miyawaki S, Imai H, et al. Differences in clinical features among different onset patterns in moyamoya disease. J Clin Med. 2021;10:13.
   Google Scholar
• Hishikawa T, Sugiu K, Date I. Moyamoya disease: a review of clinical research. Acta Med Okayama. 2016;70(4):229–236. doi:10.18926/amo/54497
   PubMed Web of Science ®Google Scholar
• Chiang CC, Shahid AH, Harriott AM, et al. Evaluation and treatment of headache associated with moyamoya disease - a narrative review. Cephalalgia. 2022;42(6):542–552. doi:10.1177/03331024211056250
   PubMed Web of Science ®Google Scholar
• Williams TS, Westmacott R, Dlamini N, et al. Intellectual ability and executive function in pediatric moyamoya vasculopathy. Dev Med Child Neurol. 2012;54(1):30–37. doi:10.1111/j.1469-8749.2011.04144.x
   PubMed Web of Science ®Google Scholar
• Nakagawara J, Osato T, Kamiyama K, et al. Diagnostic imaging of higher brain dysfunction in patients with adult moyamoya disease using statistical imaging analysis for [123I]iomazenil single photon emission computed tomography. Neurol Med Chir. 2012;52(5):318–326. doi:10.2176/nmc.52.318
   PubMed Web of Science ®Google Scholar
• Araki Y, Takagi Y, Ueda K, et al. Cognitive function of patients with adult moyamoya disease. J Stroke Cerebrovasc Dis. 2014;23(7):1789–1794. doi:10.1016/j.jstrokecerebrovasdis.2014.04.032
   PubMed Web of Science ®Google Scholar
• Dn TB, Sudarsanan S. Moyamoya disease (presenting as schizophrenia). Indian J Psychiatry. 1981;23(2):188–189.
   PubMedGoogle Scholar
• Wu HH, Shen JY, Wang YH, et al. A rare presentation of moyamoya disease mimicking schizophrenia: a case report. Asian J Psychiatr. 2021;65:102818. doi:10.1016/j.ajp.2021.102818
   PubMed Web of Science ®Google Scholar
• Lubman DI, Pantelis C, Desmond P, Proffitt TM, Velakoulis D. Moyamoya disease in a patient with schizophrenia. J Int Neuropsychol Soc. 2003;9(5):806–810. doi:10.1017/s1355617703950132
   PubMed Web of Science ®Google Scholar
• Kronenburg A, van den Berg E, van Schooneveld MM, et al. Cognitive functions in children and adults with moyamoya vasculopathy: a systematic review and meta-analysis. J Stroke. 2018;20(3):332–341. doi:10.5853/jos.2018.01550
   PubMed Web of Science ®Google Scholar
• Kronenburg A, Deckers PT, van den Berg E, et al. The profile of cognitive impairment and hemodynamic compromise in moyamoya: a single-center prospective cohort study. J Neurosurg. 2023;138(1):173–184. doi:10.3171/2022.3.Jns212844
   PubMed Web of Science ®Google Scholar
• Hsu YH, Kuo MF, Hua MS, Yang CC. Selective neuropsychological impairments and related clinical factors in children with moyamoya disease of the transient ischemic attack type. Childs Nerv Syst. 2014;30(3):441–447. doi:10.1007/s00381-013-2271-9
   PubMed Web of Science ®Google Scholar
• Kuroda S, Houkin K, Ishikawa T, et al. Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis. Childs Nerv Syst. 2004;20(5):302–308. doi:10.1007/s00381-004-0924-4
   PubMed Web of Science ®Google Scholar
• Ezura M, Yoshimoto T, Fujiwara S, Takahashi A, Shirane R, Mizoi K. Clinical and angiographic follow-up of childhood-onset moyamoya disease. Childs Nerv Syst. 1995;11(10):591–594. doi:10.1007/bf00300998
   PubMed Web of Science ®Google Scholar
• Matsushima Y, Aoyagi M, Masaoka H, Suzuki R, Ohno K. Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age. Childs Nerv Syst. 1990;6(8):440–443. doi:10.1007/bf00302089
   PubMed Web of Science ®Google Scholar
• Kurokawa T, Tomita S, Ueda K, et al. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol. 1985;1(5):274–277. doi:10.1016/0887-8994(85)90027-x
   PubMedGoogle Scholar
• Imaizumi C, Imaizumi T, Osawa M, Fukuyama Y, Takeshita M. Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics. 1999;30(6):294–299. doi:10.1055/s-2007-973508
   PubMed Web of Science ®Google Scholar
• Liu Z, He S, Xu Z, et al. Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease. BMC Neurol. 2020;20(1):302. doi:10.1186/s12883-020-01876-0
   PubMed Web of Science ®Google Scholar
• Su SH, Hai J, Zhang L, Yu F, Wu YF. Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization. Eur J Neurol. 2013;20(7):1081–1087. doi:10.1111/ene.12138
   PubMed Web of Science ®Google Scholar
• Uchida S, Kubo Y, Oomori D, et al. Long-term cognitive changes after revascularization surgery in adult patients with ischemic moyamoya disease. Cerebrovasc Dis Extra. 2021;11(3):145–154. doi:10.1159/000521028
   PubMed Web of Science ®Google Scholar
• Karzmark P, Zeifert PD, Bell-Stephens TE, Steinberg GK, Dorfman LJ. Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery. 2012;70(3):634–638. doi:10.1227/NEU.0b013e3182320d1a
   PubMed Web of Science ®Google Scholar
• Festa JR, Schwarz LR, Pliskin N, et al. Neurocognitive dysfunction in adult moyamoya disease. J Neurol. 2010;257(5):806–815. doi:10.1007/s00415-009-5424-8
   PubMed Web of Science ®Google Scholar
• Karzmark P, Zeifert PD, Tan S, Dorfman LJ, Bell-Stephens TE, Steinberg GK. Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery. 2008;62(5):1048–51; discussion 1051–2. doi:10.1227/01.neu.0000325866.29634.4c
   PubMed Web of Science ®Google Scholar
• Richards M, Grzenda A, Nelson E, Gitlin M. Psychiatric comorbidity in moyamoya disease and preliminary guidelines for treatment. Am J Psychiatry. 2019;176(4):269–274. doi:10.1176/appi.ajp.2018.18040404
   PubMed Web of Science ®Google Scholar
• Gomez CR, Hogan PA. Unilateral Moya Moya disease in an adult--a case history. Angiology. 1987;38(4):342–346. doi:10.1177/000331978703800409
   PubMed Web of Science ®Google Scholar
• O’Sullivan DJ, Lim GH, Darveniza P, Coffey GL. Multiple progressive intracranial arterial occlusions (‘moyamoya’ disease). J Neurol Neurosurg Psychiatry. 1977;40(9):853–860. doi:10.1136/jnnp.40.9.853
   PubMed Web of Science ®Google Scholar
• Lee KO, Lee KY. Fluctuating frontal lobe dysfunction in a patient with moyamoya disease. Neurol Sci. 2011;32(4):743–746. doi:10.1007/s10072-010-0474-3
   PubMed Web of Science ®Google Scholar
• Klasen H, Britton J, Newman M. Moyamoya disease in a 12-year-old Caucasian boy presenting with acute transient psychosis. Eur Child Adolesc Psychiatry. 1999;8(2):149–153. doi:10.1007/s007870050096
   PubMed Web of Science ®Google Scholar
• Behere RV, John M, Sureshkumar R, et al. Mood disorder in association with moyamoya disease. Psychiatry Clin Neurosci. 2012;66(2):163–164. doi:10.1111/j.1440-1819.2011.02317.x
   PubMed Web of Science ®Google Scholar
• Mohapatra S, Sahoo AJ. Neuropsychiatric manifestations in a child with moyamoya disease. J Neurosci Rural Pract. 2016;7(2):331–332. doi:10.4103/0976-3147.176198
   PubMedGoogle Scholar
• Schwarz LR, Thurstin AH, Levine LA. A single case report of Moyamoya disease presenting in a psychiatric setting. Appl Neuropsychol. 2010;17(1):73–77. doi:10.1080/09084280903519831
   PubMed Web of Science ®Google Scholar
• Zalonis I, Christidi F, Kararizou E, Triantafyllou NI, Spengos K, Vassilopoulos D. Cognitive deficits presenting as psychiatric symptoms in a patient with Moyamoya disease. Psychol Rep. 2010;107(3):727–732. doi:10.2466/02.13.15.22.Pr0.107.6.727-732
   PubMed Web of Science ®Google Scholar
• Iivanainen M, Vuolio M, Halonen V. Occlusive disease of intracranial main arteries with collateral networks (moyamoya disease) in adults. Acta Neurol Scand. 1973;49(3):307–322. doi:10.1111/j.1600-0404.1973.tb01303.x
   PubMed Web of Science ®Google Scholar
• Zhang P, Xu Q, Dai J, Wang J, Zhang N, Luo Y. Dysfunction of affective network in post ischemic stroke depression: a resting-state functional magnetic resonance imaging study. Biomed Res Int. 2014;2014:846830. doi:10.1155/2014/846830
   PubMed Web of Science ®Google Scholar
• Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–1018. doi:10.1016/s1474-4422(09)70236-4
   PubMed Web of Science ®Google Scholar
• He S, Duan R, Liu Z, et al. Characteristics of cognitive impairment in adult asymptomatic moyamoya disease. BMC Neurol. 2020;20(1):322. doi:10.1186/s12883-020-01898-8
   PubMed Web of Science ®Google Scholar
• Shen J, Xu Z, Liu Z, Duan Y, Wei W, Chang J. Association between white matter hyperintensities burden and cognitive function in adult asymptomatic moyamoya disease. J Clin Med. 2023;12:3.
   Web of Science ®Google Scholar
• Serra S, Kugler J, Hug M, Hackenberg A, Latal B, Khan N. Preoperative neurodevelopment of children with moyamoya angiopathy. Dev Med Child Neurol. 2021;63(2):218–225. doi:10.1111/dmcn.14708
   PubMed Web of Science ®Google Scholar
• Kang CG, Chun MH, Kang JA, Do KH, Choi SJ. Neurocognitive dysfunction according to hypoperfusion territory in patients with moyamoya disease. Ann Rehabil Med. 2017;41(1):1–8. doi:10.5535/arm.2017.41.1.1
   PubMedGoogle Scholar
• Calviere L, Catalaa I, Marlats F, et al. Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease. Clinical article.. J Neurosurg. 2010;113(4):753–759. doi:10.3171/2010.4.Jns091808
   PubMed Web of Science ®Google Scholar
• Calviere L, Ssi Yan Kai G, Catalaa I, Marlats F, Bonneville F, Larrue V. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter. J Neurol Neurosurg Psychiatry. 2012;83(6):591–593. doi:10.1136/jnnp-2011-301388
   PubMed Web of Science ®Google Scholar
• Sato H, Sato N, Tamaki N, Matsumoto S. Chronic low-perfusion state in children with moyamoya disease following revascularization. Childs Nerv Syst. 1990;6(3):166–171. doi:10.1007/bf00308495
   PubMed Web of Science ®Google Scholar
• Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–1237. doi:10.1056/NEJMra0804622
   PubMed Web of Science ®Google Scholar
• Kawaguchi S, Okuno S, Sakaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg. 2000;93(3):397–401. doi:10.3171/jns.2000.93.3.0397
   PubMed Web of Science ®Google Scholar
• Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus. 2008;24(2):E15. doi:10.3171/foc/2008/24/2/e15
   PubMed Web of Science ®Google Scholar
• Fiaschi P, Scala M, Piatelli G, et al. Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome. Neurosurg Rev. 2021;44(4):1877–1887. doi:10.1007/s10143-020-01393-1
   PubMed Web of Science ®Google Scholar
• Matsushima Y, Aoyagi M, Nariai T, Takada Y, Hirakawa K. Long-term intelligence outcome of post-encephalo-duro-arterio-synangiosis childhood moyamoya patients. Clin Neurol Neurosurg. 1997;99(Suppl 2):S147–S150. doi:10.1016/s0303-8467(97)00055-3
   PubMedGoogle Scholar
• Ando T, Shimada Y, Fujiwara S, et al. Revascularisation surgery improves cognition in adult patients with moyamoya disease. J Neurol Neurosurg Psychiatry. 2020;91(3):332–334. doi:10.1136/jnnp-2019-321069
   PubMed Web of Science ®Google Scholar
• Ishii R, Takeuchi S, Ibayashi K, Tanaka R. Intelligence in children with moyamoya disease: evaluation after surgical treatments with special reference to changes in cerebral blood flow. Stroke. 1984;15(5):873–877. doi:10.1161/01.str.15.5.873
   PubMed Web of Science ®Google Scholar
• Matsushima Y, Aoyagi M, Koumo Y, et al. Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients--swift disappearance of ischemic attacks and maintenance of mental capacity. Neurol Med Chir. 1991;31(11):708–714. doi:10.2176/nmc.31.708
   PubMedGoogle Scholar
• Veeravagu A, Guzman R, Patil CG, Hou LC, Lee M, Steinberg GK. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus. 2008;24(2):E16. doi:10.3171/foc/2008/24/2/e16
   PubMed Web of Science ®Google Scholar
• Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 1992;77(1):84–89. doi:10.3171/jns.1992.77.1.0084
   PubMed Web of Science ®Google Scholar
• Lee JY, Phi JH, Wang KC, Cho BK, Shin MS, Kim SK. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. Cerebrovasc Dis. 2011;31(3):230–237. doi:10.1159/000321901
   PubMed Web of Science ®Google Scholar
• Deckers PT, Kronenburg A, van den Berg E, et al. Clinical outcome, cognition, and cerebrovascular reactivity after surgical treatment for moyamoya vasculopathy: a Dutch prospective, single-center cohort study. J Clin Med. 2022;11:24.
   Web of Science ®Google Scholar
• Hsu YH, Chen YF, Yang SH, Yang CC, Kuo MF. Postoperative change of neuropsychological function after indirect revascularization in childhood moyamoya disease: a correlation with cerebral perfusion study. Childs Nerv Syst. 2020;36(6):1245–1253. doi:10.1007/s00381-019-04432-5
   PubMed Web of Science ®Google Scholar
• Kim W, Lee EY, Park SE, et al. Neuropsychological impacts of indirect revascularization for pediatric moyamoya disease. Childs Nerv Syst. 2018;34(6):1199–1206. doi:10.1007/s00381-018-3804-z
   PubMed Web of Science ®Google Scholar
• Scala M, Fiaschi P, Capra V, et al. When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience. Childs Nerv Syst. 2018;34(7):1311–1323. doi:10.1007/s00381-018-3833-7
   PubMed Web of Science ®Google Scholar
• Baek HJ, Chung SY, Park MS, Kim SM, Park KS, Son HU. Preliminary study of neurocognitive dysfunction in adult moyamoya disease and improvement after superficial temporal artery-middle cerebral artery bypass. J Korean Neurosurg Soc. 2014;56(3):188–193. doi:10.3340/jkns.2014.56.3.188
   PubMed Web of Science ®Google Scholar
• Zeifert PD, Karzmark P, Bell-Stephens TE, Steinberg GK, Dorfman LJ. Neurocognitive performance after cerebral revascularization in adult moyamoya disease. Stroke. 2017;48(6):1514–1517. doi:10.1161/strokeaha.116.016028
   PubMed Web of Science ®Google Scholar
• Yanagihara W, Chida K, Kobayashi M, et al. Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. J Neurosurg. 2018;131(6):1716–1724. doi:10.3171/2018.7.Jns18149
   PubMed Web of Science ®Google Scholar
• Kazumata K, Tha KK, Tokairin K, et al. Brain structure, connectivity, and cognitive changes following revascularization surgery in adult moyamoya disease. Neurosurgery. 2019;85(5):E943–E952. doi:10.1093/neuros/nyz176
   PubMed Web of Science ®Google Scholar
• Wityk RJ, Hillis A, Beauchamp N, Barker PB, Rigamonti D. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report. Neurosurgery. 2002;51(6):1499–505; discussion 1506.
   PubMed Web of Science ®Google Scholar
• Jefferson AL, Glosser G, Detre JA, Sinson G, Liebeskind DS. Neuropsychological and perfusion MR imaging correlates of revascularization in a case of moyamoya syndrome. AJNR Am J Neuroradiol. 2006;27(1):98–100.
   PubMed Web of Science ®Google Scholar
• Hara S, Kudo T, Hayashi S, et al. Improvement in cognitive decline after indirect bypass surgery in adult moyamoya disease: implication of (15)O-gas positron emission tomography. Ann Nucl Med. 2020;34(7):467–475. doi:10.1007/s12149-020-01473-8
   PubMed Web of Science ®Google Scholar